In vitro models to study mechanisms involved in cyclosporine A- mediated glomerular contraction

Archives of Toxicology

Volumn 73, Issue 6, 1999, Pages 337-345

  L'Azou, B ^b   Medina, J ^a   Frieauff, W ^a   Cordier, A ^a   Cambar, J ^b   Wolf, A ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Cyclosporin; Intracellular mediators; Isolated glomeruli; Mesangial cells; Vasoreactivity

Indexed keywords

CALCIUM; CYCLOSPORIN A; ENDOTHELIN 1; PROSTACYCLIN; REACTIVE OXYGEN METABOLITE; THROMBOXANE A2; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM CELL LEVEL; CELL STRUCTURE; CONCENTRATION RESPONSE; DRUG CYTOTOXICITY; DRUG INHIBITION; GLOMERULUS; GLOMERULUS FILTRATION RATE; IMMUNOSUPPRESSIVE TREATMENT; MALE; MESANGIUM CELL; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; TIME; ULTRAFILTRATION; VASOCONSTRICTION;

ANIMALS; CALCIUM; CELLS, CULTURED; CYCLOSPORINE; ENDOTHELIN-1; EPOPROSTENOL; GLOMERULAR MESANGIUM; IMMUNOSUPPRESSIVE AGENTS; KIDNEY GLOMERULUS; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; THROMBOXANE A2;

ANIMALIA; GLOMERULUS;

EID: 0032843957     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002040050627     Document Type: Article

References (82)

1. Ardaillou R, Sraer J, Chansel D, Ardaillou R, Sraer JD (1981) The effect of angiotensin II on isolated glomeruli and cultured glomerular cells. Kidney Int 31: 574-580
2. Balleran BJ, Marsden PA (1991) Endothelium-derived vasoactive mediators and renal glomerular function. Clin Invest Med 14: 508-517
3. Barros EJ, Boim MA, Ajzen H, Ramos OL, Schor N (1987) Glomerular hemodynamics and hormonal participation on cyclosporine nephrotoxicity. Kidney Int 32: 19-25
4. Baud L, Ardaillou R (1986) Reactive oxygen species: production and role in the kidney. Am J Physiol 251 (Renal Fluid Electrolyte Physiol): F765-F776
5. Bennet WM (1990) Renal effects of cyclosporine. J Am Acad Dermatol 23: 1280
6. 2 in rat with cyclosporin A nephrotoxicity. Kidney Int 34: 164-168
7. Booth P, Dawidson I, Glothier N, Diller K (1988) In vivo fluorescence microscopy of kidney subcapsular blood flow in mice. Transplantation 46: 566-569
8. Borel JL, Feurer C, Gubler HU, Stahelin H (1976) Biological effect of cyclosporine A. A new antilymphotic agent. Agents Actions 6: 468-475
9. Borel JF, Baumann G, Chapman I, Donastsch P, Fahr A, Mueller EA, Vigouret JM (1996) In vivo pharmacological effects of cyclosporin and some analogues. Adv Pharmacol 35
10. Bradford MM (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilising the principle of protein dye binding. Anal Biochem 72: 248-254
11. Cambar J, Saurel J, Canellas J (1978) The myorelaxant effect of theophylline on smooth muscle cells of the afferent arterioles and glomerular tuft. Eur J Pharmacol 49: 193-196
12. Copeland KR, Yastcoff RW (1992) Comparison of the effects of cyclosporine and its metabolites on the release of prostacyclin and endothelin from mesangial cells. Transplantation 53: 640-645
13. Demers LM, Derck DD (1980) A radioimmunoassay for 6-keto-prostaglandin F1α. Prostaglandin Thromboxane Res 6: 193-199
14. Dieperink H (1987) Mechanism of cyclosporine A nephrotoxicity - rat to man. In: Bach PH (ed) Nephrotoxicity in vitro to in vivo, animals to man. Plenum Press, New York, pp 277-282
15. Duque I, Garcia-Escribano C, Rodriguez-Puyol M, Diez-Marques ML, Lopez-Novoa JM, Arribas I, Hernando L, Rodriguez-Puyol D (1992) Effects of reactive oxygen species on cultured rat mesangial cells and isolated rat glomeruli. Am J Physiol 263 (Renal Fluid Electrolyte Physiol 32): F466-F473
16. English J, Evan A, Houghton DC, Bennett WM (1987) Cyclosporine-induced acute renal dysfunction in the rat. Transplantation 44: 135-141
17. Frenkel K, Gleichauf C (1991) Hydrogen peroxide formation by cells treated with a tumor promoter. Free Rad Res Commun 12: 783-794
18. Golberg HK, Wong PY, Cole EH, Levy GA, Skorecki KL (1989) Dissociation between the immunosuppressive activity of cyclosporine derivatives and their effects on intracellular calcium signalling in mesangial cells. Transplantation 47: 731-733
19. Gonzalez R, Redon P, Lakhdar B, Potaux L, Cambar J (1990) Cyclosporine nephrotoxicity assessed in isolated human glomeruli and cultured mesangial cells. Toxicol In Vitro 4: 391-395
20. Gotze S, Auch-Schwelk W, Bossaller C, Thelen J, Fleck E (1994) Preventive effects of diltiazem on cyclosporin A-induced vascular smooth muscle dysfunction. Transpl Int 7: 157-162
21. Grandstrom E, Kindahl H (1978) Radioimmunoassay of prostaglandins and thromboxanes. In: Methods Prostaglandin Res 5: 119-210
22. Grieve EM, Hawksworth GM, Simpson JG, Whiting PH (1990) Effect of thromboxane synthase inhibition and angiotensin converting enzyme inhibition on acute cyclosporin A nephrotoxicity. Biochem Pharmacol 40: 2323-2329
23. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440-3450
24. Hajjar RJ, Bonventre JV (1991) Oscillations of intracellular calcium induced by vasopressin in individual Fura 2 loaded mesangial cells. J Biol Chem 226: 21589-21594
25. Heering P, Strobach H, Schror K, Grabense B (1992) The role of thromboxane and prostacyclin in cyclosporin-induced nephrotoxicity. Nephron 61: 26-31
26. Huang LQ, Whitworth JA, Chestermen CN (1995) Effect of cyclosporin A and dexamethasone on haemostatic and vasoactive functions of vascular endothelial cells. Blood Coagul Fibrinolysis 6: 438-445
27. Kahan BD (1989) Cyclosporine. N Engl J Med 321: 1725-1738
28. Katoh T, Chang H, Uchida S, Okuda T, Kurokawa K (1990) Direct effects of endothelin in the rat kidney. Am J Physiol 258 (Renal Fluid Electrolyte Physiol 27): F397-F402
29. Kim YJ, Park YH, Moon HK (1997) Reduction of chronic cyclosporin nephrotoxicity by thromboxane synthase inhibition with OKY-046. Kidny Blood Press Res 20: 38-43
30. Kon V, Sugiura M, Inagami T, Harvie BR, Ichikawa I, Hoover R (1990a) Role of endothelin in cyclosporine-induced glomerular dysfunction. Kidney Int 37: 1487-1491
31. Kon V, Sugiura M, Inagami T (1990b) Cyclosporin causes endothelin-dependent acute renal failure. Kidney Int 37: 298A
32. Krysztopik RJ, Bentley FR, Spain DA, Wilson MA, Garrison RN (1997) Lazaroids prevent acute cyclosporine-induced renal vasoconstriction. Transplantation 63: 1215-1220
33. Kunz D, Walker G, Eberhardt W, Nitsch D, Pfeilschifter J (1995) Interleukin 1 beta-induced expression of nitric oxide synthase in rat renal mesangial cells is suppressed by cyclosporin A. Biochem Biophys Res Commun 216: 438-446
34. Kunz J, Hall MN (1993) Cyclosporin A, FK 506 and rapamycin: more than just immunosuppression. Trends Biochem Sci 18: 334-338
35. Latta H (1973) Ultrastructure of the glomerulus and juxtaglomerular apparatus. Handbook of renal physiology. Am J Soc 8: 1-29
36. L'Azou B, Cambar J (1993) Prevention of cyclosporin-induced vasoconstrictive effect in rat isolated glomeruli with pharmacological vasoactive agents. Toxic In Vitro 7: 417-420
37. L'Azou B, Cambar J (1994) Use of two in vitro models to study the renal vasoreactivity of cyclosporin. Transpl Proc 26: 2883-2885
38. L'Azou B, Lakhdar B, Potaux L, Cambar J (1994) Protective effect of verapamil in cyclosporin-incubated human and murine isolated glomeruli. Renal Failure 16: 665-672
39. LeGuen E, Morel D, L'Azou B, Cambar J, Potaux L (1994) Effect of cyclosporin and the prostacyclin analogue iloprost on human glomerular vasoreactivity. Nephrology dialysis. Transplantation 9: 413-415
40. Locher R, Huss R, Vetter W (1991) Potentiation of vascular smooth muscle cell activity by cyclosporin A. Eur J Clin Pharmacol 41: 297-301
41. Lopez-Farre A, Gomez-Garre D, Bernadeu F, Montanes I, Millas I, Lopez-Novoa JM (1991) Renal effects and mesangial cell contraction induced by endothelin are mediated by PAF. Kidney Int 39: 624-630
42. Lo Russo A, Passaquin AC, Ruegg UT (1997) Mechanism of enhanced vasoconstriction hormone action in vascular smooth muscle cells by cyclosporin A. Br J Pharmacol 121: 248-252
43. Luscher TF, Yang Z (1993) Calcium antagonist and ACE inhibitors. Effect on endothelium and vascular smooth muscle. Drugs 46: 121-132
44. Madsen JK, Zachariae H, Pedersen EB (1997) Effects of the calcium antagonist felodipine on renal haemodynamics, tubular sodium handling and blood pressure in cyclosporin-treated dermatological patients. Nephrol Dial Transplant 12: 480-484
45. Masaki T, Yanagisawa M (1990) Cardiovascular effects of the endothelins. Cardiovasc Drug Rev 8: 373
46. Mason J (1990) Pharmacology of cyclosporine: VII. Pathophysiology and toxicology of cyclosporine in humans and animals. Pharmacol Rev 41: 423
47. Medina J, Cordier A, Wolf A (1997) Cyclosporine A-induced contraction of isolated rat aortic smooth muscle cells. Life Sci 61: 327-332
48. Mene P, Simonson MS, Dunn MJ (1989) Physiology of the mesangial cell. Physiol Rev 69: 1347-1424
49. 2+ mobilization and contraction in mesangial cells. Kidney Int 34: 89-97
50. Meyer-Lehnert H, Bokemeyer D, Friedrichs U, Drechsler S, Kramer HJ (1993) Cellular signaling by cyclosporine A in contractile cells: interactions with atrial natriuretic peptide. Clin Invest 71: 153-160
51. Meyer-Lehnert H, Bokemeyer D, Friedrichs U, Backer A, Kramer HJ (1997) Cellular mechanisms of cyclosporine A-associated side effects: role of endothelin. Kidney Int 61: S27-S31
52. Mourad G, Ribstein J, Mimran A (1993) Converting-enzyme inhibitor versus calcium antagonist in cyclosporine-treated renal transplants. Kidney Int 43: 419-425
53. Murray BM, Paller MS, Ferris TF (1985) Effect of cyclosporine administration on renal hemodynamics in conscious rat. Kidney Int 28: 767-774
54. 1-cells. Eur J Pharmacol 180: 191-192
55. 1. J Cardiovasc Pharmacol 17: S172-S173
56. Ong AC, Jowett TP, Scoble JE, O'Shea JA, Varghese Z, Moorhead JF (1993) Effect of cyclosporin A on endothelin synthesis by cultured human renal cortical epithelial cells. Nephrol Dial Transplant 8: 748-753
57. Oriji GK, Keiser HR (1997) Cyclosporine A-induced contractions and prostacyclin release are maintained by cellular calcium in rat aortic rings: role of protein kinase C. Prostaglandins Leukot Essent Fatty acids 52: 151-156
58. Para T, de Arriba G, Perez de Lema G, Rodriguez-Puyol D, Rodriguez-Puyol M (1998) Cyclosporine A nephrotoxicity : role of thromboxane and reactive oxygen. J Lab Clin Med 131: 63-70
59. Perico N, Dadan J, Remuzzi G (1990) Endothelin mediates the renal vasoconstriction induced by cyclosporine in the rat. J Am Soc Nephrol 1: 76-83
60. Petric R, Freeman D, Wallace C, McDonald J, Stiller C, Keon P (1988) Effect of cyclosporine on urinary prostano excretion, renal blood flow and glomerulotubular function. Transplantation 45: 883-889
61. Pfeilschifter J (1988) Cyclosporin A augments vasoconstrictor-induced rise in intracellular free calcium in rat mesangial cells. Biochem Pharmacol 37: 4205-4210
62. Pfeilschifter J, Baeur C (1986) Pertussis toxin abolishes angiotensin II-induced phosphoinositide hydrolysis and prostaglandin synthesis in rat renal mesangial cells. Biochem J 236: 289-294
63. Potier M, Winicki J, Cambar J (1996) Nitric oxide (NO) donor 3-morpholinosydonimine antagonizes cyclosporin A-induced contraction in two in vitro glomerular models. Cell Biol Toxicol 12: 335-339
64. Potier M, Aparicio M, Cambar J (1997) Protective effect of three xanthine derivatives against the cyclosporin A-induced glomerular contraction in isolated glomeruli and culture mesangial cells. Nephron 77: 427-434
65. Radeke HH, Kuster S, Kaever V, Resch K (1993) Effects of cyclosporin and FK-506 on glomerular mesangial cells. Evidence for direct inhibition of thromboxane synthase by low cyclosporin concentrations. Eur J Clin Pharmacol 44 (Suppl 1): 811-816
66. Roderia JL, Morazles JM, Alcazar JM, Ruilope LM (1993) Calcium antagonists and renal protection. J Hypertens (Suppl) 11: S49-S53
67. Roe MW, Lemasters JJ, Herman B (1990) Assessement of Fura 2 for measurements of cytosolic calcium. Cell Calcium 11: 63-73
68. Ryffel B, Siegl H (1992) Experimental cyclosporin nephrotoxicity. In: Burdick JF, Racusen LC, Solez K, Williams G (eds) Kidney transplant rejection 2nd edn
69. Sigal NH, Dumont FJ (1992) Cyclosporin A, Fk 506 and rapamycin: phamacologic probes of lymphocyte signal transduction. Annu Rev Immunol 10: 519-560
70. Simonson MS (1993) Endothelins: multifunctional renal peptides. Physiol Rev 73: 375
71. Spurney RF, Mayros SD, Collins D, Ruiz P, Klotmann PE, Coffman T (1990) Thromboxane receptor blockade improves cyclosporine nephrotoxicity in rats. Prostaglandins 55: 135-147
72. 2 formation by rat mesangial cells in culture. Kidney Int 35: 1161
73. Stoes E S, Luscher TF, de Groot FG, Kommans HA, Rabelink TJ (1997) Cyclosporin A increases nitric oxide activity in vivo. Hypertension 29: 570-575
74. Takeda M, Breyer MD, Noland TD, Hoover RL, Inagami T, Kon V (1992) Endothelin-1 receptor antagonist: effects on endothelin-and cyclosporine-treated mesangial cells. Kidney Int 41: 1713-1719
75. Takeda Y, Itoh Y, Yoneda T, Miyamori I, Takeda R (1993) Cyclosporine A induces endothelin-1 release from cultured rat vascular smooth muscle cells. Eur J Pharmacol 233: 299-301
76. Voss BL, Hamilton KK, Samara ES, McKee PA (1988) Cyclosporine suppression of endothelial prostacyclin generation. Transplantation 45: 793-796
77. Wang C, Salahudeen AK (1995) Lipid peroxidation accompanies cyclosporine nephrotoxicity: effect of vitamin E. Kidney Int 47: 927-934
78. B receptors mediate vasoconstriction and prostanoid release in the isolated kidney of the rat. Eur J Pharmacol 250: 447-453
79. Wolf A, Clemann N, Frieauff W, Ryffel B, Cordier A (1994) Role of reactive oxygen formation in the cyclosporin A-mediated impairment of renal functions. Transpl Proc 26: 2902-2907
80. Xue H, Bukoski RD, Carron DA, Bennet W (1987) Induction of contraction in isolated rat aorta by cyclosporin. Transpl Proc 43: 715-718
81. Yaris E, Tuncer M, Kayaalp SO, Ilhan M (1994) Direct vascular smooth muscle contractile effect of cyclosporin A and its vehicle in rabbit isolated arteries. Arch Int Pharmacodyn Ther 327: 166-174
82. 2+ release. Modification by agonist stimulation. J Biol Chem 268: 10997-11001